MC2150A1 - Utilisation de derives d'acides alkylphophoriques pour la lutte contre les maladies du type psoriasis - Google Patents

Utilisation de derives d'acides alkylphophoriques pour la lutte contre les maladies du type psoriasis

Info

Publication number
MC2150A1
MC2150A1 MC902151A MC2151A MC2150A1 MC 2150 A1 MC2150 A1 MC 2150A1 MC 902151 A MC902151 A MC 902151A MC 2151 A MC2151 A MC 2151A MC 2150 A1 MC2150 A1 MC 2150A1
Authority
MC
Monaco
Prior art keywords
alkylphophoric
control
acid derivatives
psoriasis diseases
psoriasis
Prior art date
Application number
MC902151A
Other languages
English (en)
French (fr)
Inventor
Hansjoerg Eibl Prof
Clemens Unger Dr
Dr Juergen Engel Prof
Original Assignee
Asta Pharma
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6390272&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MC2150(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asta Pharma, Max Planck Gesellschaft filed Critical Asta Pharma
Publication of MC2150A1 publication Critical patent/MC2150A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MC902151A 1989-09-27 1990-09-25 Utilisation de derives d'acides alkylphophoriques pour la lutte contre les maladies du type psoriasis MC2150A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3932183 1989-09-27

Publications (1)

Publication Number Publication Date
MC2150A1 true MC2150A1 (fr) 1992-03-10

Family

ID=6390272

Family Applications (1)

Application Number Title Priority Date Filing Date
MC902151A MC2150A1 (fr) 1989-09-27 1990-09-25 Utilisation de derives d'acides alkylphophoriques pour la lutte contre les maladies du type psoriasis

Country Status (17)

Country Link
EP (2) EP0419998A3 (lv)
JP (1) JP3176615B2 (lv)
CA (1) CA2026278C (lv)
DD (1) DD298052A5 (lv)
DE (1) DE4029747C2 (lv)
EG (1) EG19338A (lv)
FI (1) FI904726A0 (lv)
HU (1) HU209589B (lv)
IE (1) IE903464A1 (lv)
LT (1) LT3804B (lv)
LV (1) LV10391B (lv)
MC (1) MC2150A1 (lv)
NO (1) NO904184L (lv)
PT (1) PT95422B (lv)
RU (1) RU1837877C (lv)
UA (1) UA19335A (lv)
ZA (1) ZA907702B (lv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4233044A1 (de) * 1992-10-01 1994-04-07 Asta Medica Ag Phospholipidderivate, die höhere Elemente der V. Hauptgruppe enthalten
US5958906A (en) * 1992-10-01 1999-09-28 Asta-Medica Aktiengesellschaft Phospholipid derivatives containing higher elements of the fifth main group
DE4235911A1 (de) * 1992-10-23 1994-04-28 Asta Medica Ag Stabilisierte Hexadecylphosphocholinlösungen in Glycerinalkylethern
DE69804865T2 (de) 1998-01-22 2002-11-07 Zentaris Ag Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
DE102006004821B4 (de) * 2006-01-30 2020-12-10 Cuma Kilic Sammelbehältnis für Abfall und Bauschutt
JP2012532154A (ja) * 2009-07-09 2012-12-13 エキスパーゲン ドラッグ デベロプメント ゲーエムベーハー アルキルホスホコリンの液状医薬製剤及びその製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761404A (en) * 1985-07-01 1988-08-02 Merck & Co., Inc. Phospholipid analogs useful as PAF synthesis inhibitors
CA1280369C (en) * 1985-12-04 1991-02-19 Hansjorg Eibl Pharmaceutical with anti-tumor effect
DE3829899C2 (de) * 1988-09-02 1994-12-15 Reutter Werner Glyceringlycophosphatide und diese enthaltende pharmazeutische Mittel zur Bekämpfung von Hauterkrankungen

Also Published As

Publication number Publication date
FI904726A0 (fi) 1990-09-26
LV10391A (lv) 1995-02-20
EP0419998A3 (en) 1991-10-23
HUT55992A (en) 1991-07-29
UA19335A (uk) 1997-12-25
ZA907702B (en) 1991-07-31
EP0916343A1 (de) 1999-05-19
HU209589B (en) 1994-08-29
JPH03130228A (ja) 1991-06-04
RU1837877C (ru) 1993-08-30
EP0419998A2 (de) 1991-04-03
LV10391B (en) 1995-10-20
PT95422B (pt) 1997-07-31
NO904184D0 (no) 1990-09-26
IE903464A1 (en) 1991-04-10
DE4029747A1 (de) 1991-04-11
LT3804B (en) 1996-03-25
PT95422A (pt) 1991-05-22
CA2026278C (en) 1996-04-30
EG19338A (en) 1994-12-30
LTIP1488A (en) 1995-06-26
DE4029747C2 (de) 2003-10-02
DD298052A5 (de) 1992-02-06
JP3176615B2 (ja) 2001-06-18
HU906233D0 (en) 1991-03-28
NO904184L (no) 1991-04-02
CA2026278A1 (en) 1991-03-28

Similar Documents

Publication Publication Date Title
MA21682A1 (fr) Procede de preparation d'agents therapeutiques derives de la quainclidine.
IS3529A7 (is) Hliðstæð aðferð við framleiðslu á meðferðarvirkum bis-aza-bísýklískum efnasamböndum
NO851695L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-heteroaryl-tiazol-derivater
FR2499414B1 (fr) Production d'anticorps proteiniques humains
MA21413A1 (fr) Nouveau procede de preparation d'alcoxy-guanine
FR2627493B1 (fr) Procede de preparation de derives d'isoquinoleine
TR22747A (tr) Vagon sueratinin kontrol edilmesine elverisli geciktiriciler
MC2150A1 (fr) Utilisation de derives d'acides alkylphophoriques pour la lutte contre les maladies du type psoriasis
FR2630735B1 (fr) Procede de preparations d'halogenophenols
FR2565590B1 (fr) Procede de preparation d'aminohydroxycephamcarboxylates
FR2576902B1 (fr) Procede de fabrication d'hydrogeno-silanes
FI93216C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
CS22891A2 (en) Application of benzylphosphonic acid's derivatives for treatment of virusinduced diseases
FR2561645B1 (fr) Procede de preparation d'acides hydroxyalkylaminoacetiques
FR2628420B1 (fr) Procede pour la preparation du methocarbamol
IT1274494B (it) Procedimento fotochimico per la preparazione dell'acido 13-cis-retinoico
FR2630741B1 (fr) Procede de preparation d'acryloyloxyethoxymethyl-melamines
GR3000552T3 (en) Use of 7-chloroquinoline-8-carboxylic acids for influencing the development of crops
FR2610924B1 (fr) Procede de preparation d'hydroxybiphenyles
FR2560199B1 (fr) Procede de preparation de l'i-brassicasterol
IT9021609A0 (it) Impianto per la produzione di calzature e procedimento per l'impiego di detto impianto
NO852741L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklopenta (b)tiofen-6-karboksylsyre-derivater
FR2564833B1 (fr) Procede de preparation de derives d'imidazolidine
RO91889A2 (ro) Procedeu pentru prepararea azobisizobutironitrilului
FR2572072B1 (fr) Procede de preparation de derives d'indole

Legal Events

Date Code Title Description
YP Annual fee paid